Asia Pacific Human Microbiome Market to 2025 - Regional Analysis and Forecasts by Product (Probiotics, Foods, Prebiotics, Medical Foods, Diagnostic Device, Drugs, and Supplements), Disease (Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders, and Others), Application (Therapeutics and Diagnostics), and Country

PART 1. INTRODUCTION

1.1 SCOPE OF THE STUDY

1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

PART 2. ASIA PACIFIC HUMAN MICROBIOME MARKET - KEY TAKEAWAYS

PART 3. ASIA PACIFIC HUMAN MICROBIOME MARKET - MARKET LANDSCAPE

3.1 OVERVIEW

3.2 MARKET SEGMENTATION

3.2.1 Asia Pacific Human Microbiome Market - By Product

3.2.2 Asia Pacific Human Microbiome Market - By Disease

3.2.3 Asia Pacific Human Microbiome Market - By Application

3.2.4 Asia Pacific Human Microbiome Market North America

3.3 PEST ANALYSIS

3.3.1 Asia Pacific- PEST Analysis

PART 4. ASIA PACIFIC HUMAN MICROBIOME MARKET- KEY MARKET DYNAMICS

4.1 KEY MARKET DRIVERS

4.1.1 Rising Chronic Disease due to change in lifestyle

4.1.2 Growing interest in Human Microbiome Treatment approach

4.2 KEY MARKET RESTRAINTS

4.2.1 Stringent regulatory environment

4.2.2 Lack of Awareness About Human Microbiome Science

4.3 KEY MARKET OPPORTUNITIES

4.3.1 Growing Initiatives To Raise The Awareness in Emerging Nations

4.4 FUTURE TRENDS

4.4.1 The Human Microbiome Drug Development Is Revolutionizing The Medical Industry

4.5 IMPACT ANALYSIS

PART 5. HUMAN MICROBIOME MARKET - ASIA PACIFIC ANALYSIS

5.1 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS

5.2 MARKET POSITIONING

5.3 PERFORMANCE OF KEY PLAYERS

Enterome

Yakult Honsha Co., Ltd.

5.4 EXPERT OPINIONS

PART 6. ASIA PACIFIC HUMAN MICROBIOME MARKET ANALYSIS - BY PRODUCT

6.1 OVERVIEW

6.2 ASIA PACIFIC HUMAN MICROBIOME MARKET, BY PRODUCT, 2017 & 2025 (%)

6.3 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)

6.4 FOODS MARKET

6.4.1 Overview

6.4.2 Asia Pacific Foods Market Revenue and Forecasts to 2025 (US$ Mn)

6.5 MEDICAL FOOD MARKET

6.5.1 Overview

6.5.2 Asia Pacific Medical Food Market Revenue and Forecasts to 2025 (US$ Mn)

6.6 PROBIOTICS MARKET

6.6.1 Overview

6.6.2 Asia Pacific Probiotics Market Revenue and Forecasts to 2025 (US$ Mn)

6.7 PREBIOTICS MARKET

6.7.1 Overview

6.7.2 Asia Pacific Prebiotics Market Revenue and Forecasts to 2025 (US$ Mn)

6.8 DRUGS MARKET

6.8.1 Overview

6.8.2 Asia Pacific Drugs Market Revenue and Forecasts to 2025 (US$ Mn)

6.9 DIAGNOSTIC DEVICES MARKET

6.9.1 Overview

6.9.2 Asia Pacific Diagnostic Devices Market Revenue and Forecasts to 2025 (US$ Mn)

6.10 SUPPLEMENTS MARKET

6.10.1 Overview

6.10.2 Asia Pacific Supplements Market Revenue and Forecasts to 2025 (US$ Mn)

PART 7. ASIA PACIFIC HUMAN MICROBIOME MARKET ANALYSIS - BY DISEASE

7.1 OVERVIEW

7.2 ASIA PACIFIC HUMAN MICROBIOME MARKET, BY DISEASE, 2017 & 2025 (%)

7.3 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)

7.4 DIABETES MARKET

7.4.1 Overview

7.4.2 Asia Pacific Diabetes Market Revenue and Forecasts to 2025 (US$ Mn)

7.5 CANCER MARKET

7.5.1 Overview

7.5.2 Asia Pacific Cancer Market Revenue and Forecasts to 2025 (US$ Mn)

7.6 AUTOIMMUNE DISORDERS MARKET

7.6.1 Overview

7.6.2 Asia Pacific Autoimmune Disorders Market Revenue and Forecasts to 2025 (US$ Mn)

7.7 OBESITY MARKET

7.7.1 Overview

7.7.2 Asia Pacific Obesity Market Revenue and Forecasts to 2025 (US$ Mn)

7.8 MENTAL DISORDERS MARKET

7.8.1 Overview

7.8.2 Asia Pacific Mental Disorders Market Revenue and Forecasts to 2025 (US$ Mn)

7.9 OTHERS MARKET

7.9.1 Overview

7.9.2 Asia Pacific Others Market Revenue and Forecasts to 2025 (US$ Mn)

PART 8. ASIA PACIFIC HUMAN MICROBIOME MARKET ANALYSIS - BY APPLICATION

8.1 OVERVIEW

8.2 ASIA PACIFIC HUMAN MICROBIOME MARKET, BY APPLICATION, 2017 & 2025 (%)

8.3 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

8.4 DIAGNOSTICS MARKET

8.4.1 Overview

8.4.2 Asia Pacific Diagnostics Market Revenue and Forecasts to 2025 (US$ Mn)

8.5 THERAPEUTICS MARKET

8.5.1 Overview

8.5.2 Asia Pacific Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn)

PART 9. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025

9.1 OVERVIEW

9.2 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

9.3 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)

9.4 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)

9.5 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

9.6 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)

9.7 CHINA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

9.7.1 China Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

9.7.2 China Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)

9.7.3 China Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)

9.7.4 China Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)

9.8 JAPAN HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

9.8.1 Japan Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

9.8.2 Japan Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)

9.8.3 Japan Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)

9.8.4 Japan Human microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)

9.9 INDIA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

9.9.1 India Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

9.9.2 India Human microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)

9.9.3 India Human microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)

9.9.4 India Human microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)

PART 10. HUMAN MICROBIOME MARKET -INDUSTRY LANDSCAPE

10.1 OVERVIEW

10.2 GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET, 2015-2018

10.3 ORGANIC GROWTH STRATEGIES

10.3.1 Overview

10.3.2 Product Launch & Approvals

10.3.3 Expansion

10.3.4 Patent and license

10.4 INORGANIC GROWTH STRATEGIES

10.4.1 Overview

10.4.2 Acquisitions

10.4.3 Partnerships, Collaborations & Agreements

10.4.4 Joint Ventures

PART 11. HUMAN MICROBIOME MARKET-KEY COMPANY PROFILES

11.1 ENTEROME

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Financial Overview

11.1.4 Product Portfolio

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 MICROBIOME THERAPEUTICS, LLC

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Financial Information

11.2.4 Product Portfolio

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 REBIOTIX INC.

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Financial Overview

11.3.4 Product Portfolio

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 YAKULT HONSHA CO., LTD.

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Financial Overview

11.4.4 Product Portfolio

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 OSEL INC.

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Financial Overview

11.5.4 Product Portfolio

11.5.5 Swot Analysis

11.5.6 Key Developments

11.6 VEDANTA BIOSCIENCES, INC.

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Financial Information

11.6.4 Product Portfolio

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 METABIOMICS CORPORATE

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Financial Overview

11.7.4 Product Portfolio

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 SYNTHETIC BIOLOGICS, INC.

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Financial Information

11.8.4 Product Portfolio

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 DUPONT

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Financial Overview

11.9.4 Product Portfolio

11.9.5 SWOT Analysis

11.9.6 Key Developments

11.10 BIOMX

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Financial Information

11.10.4 Product Portfolio

11.10.5 SWOT Analysis

11.10.6 Key Developments

PART 12. APPENDIX

12.1 ABOUT THE INSIGHT PARTNERS

12.2 GLOSSARY OF TERMS

12.3 METHODOLOGY

12.3.1 Coverage

12.3.2 Secondary Research

12.3.3 Primary Research

LIST OF TABLES

TABLE 1. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)

TABLE 2. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)

TABLE 3. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 4. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)

TABLE 5. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)

TABLE 6. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 7. CHINA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)

TABLE 8. CHINA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)

TABLE 9. CHINA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 10. JAPAN HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)

TABLE 11. JAPAN HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)

TABLE 12. JAPAN HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 13. INDIA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)

TABLE 14. INDIA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)

TABLE 15. INDIA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 16. RECENT PRODUCT LAUNCHES & APPROVALS IN THE HUMAN MICROBIOME MARKET

TABLE 17. RECENT EXPANSIONS IN THE HUMAN MICROBIOME MARKET

TABLE 18. PATENT AND LICENSE ORGANIC GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET

TABLE 19. RECENT ACQUISITIONS IN THE HUMAN MICROBIOME MARKET

TABLE 20. RECENT PARTNERSHIPS & COLLABORATIONS IN THE HUMAN MICROBIOME MARKET

TABLE 21. JOINT VENTURES INORGANIC GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET

TABLE 22. GLOSSARY OF TERMS, HUMAN MICROBIOME MARKET

LIST OF FIGURES

FIGURE 1. JAPAN HUMAN MICROBIOME MARKET, REVENUE (US$ MN), 2018 & 2025

FIGURE 2. ASIA PACIFIC HUMAN MICROBIOME MARKET BY PRODUCT, MARKET SHARE (%), 2017

FIGURE 3. ASIA PACIFIC HUMAN MICROBIOME MARKET BY DISEASE, MARKET SHARE (%), 2017

FIGURE 4. ASIA PACIFIC HUMAN MICROBIOME MARKET BY APPLICATION, MARKET SHARE (%), 2017

FIGURE 5. HUMAN MICROBIOME MARKET SEGMENTATION

FIGURE 6. ASIA PACIFIC PEST ANALYSIS

FIGURE 7. HUMAN MICROBIOME MARKET IMPACT ANALYSIS OF DRIVERS & RESTRAINTS

FIGURE 8. ASIA PACIFIC HUMAN MICROBIOME MARKET - REVENUE FORECASTS AND ANALYSIS - 2017- 2025

FIGURE 9. ASIA PACIFIC HUMAN MICROBIOME MARKET, BY PRODUCT, 2017 & 2025 (%)

FIGURE 10. ASIA PACIFIC FOODS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 11. ASIA PACIFIC MEDICAL FOOD MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 12. ASIA PACIFIC PROBIOTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 13. ASIA PACIFIC PREBIOTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 14. ASIA PACIFIC DRUGS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 15. ASIA PACIFIC DIAGNOSTIC DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 16. ASIA PACIFIC SUPPLEMENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 17. ASIA PACIFIC HUMAN MICROBIOME MARKET BY DISEASE, 2017 & 2025 (%)

FIGURE 18. ASIA PACIFIC DIABETES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 19. ASIA PACIFIC CANCER MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 20. ASIA PACIFIC AUTOIMMUNE DISEASES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 21. ASIA PACIFIC OBESITY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 22. ASIA PACIFIC MENTAL DISORDERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 23. ASIA PACIFIC OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 24. ASIA PACIFIC HUMAN MICROBIOME MARKET BY APPLICATION, 2017 & 2025 (%)

FIGURE 25. ASIA PACIFIC DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 26. ASIA PACIFIC THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 27. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE, BY COUNTRY, 2017 (US$ MN)

FIGURE 28. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 29. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)

FIGURE 30. CHINA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 31. JAPAN HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 32. INDIA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 33. GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET, 2015-2018

FIGURE 34. ORGANIC GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET, 2015-2018

FIGURE 35. INORGANIC GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET, 2015-2018